News

ICICI Securities Upgrades Kajaria Ceramics Rating After Analysis

ICICI Securities Upgrades Kajaria Ceramics Rating After Analysis

ICICI Securities Adjusts Kajaria Ceramics Stock Rating

In a recent update, ICICI Securities has revised their recommendation on Kajaria Ceramics Ltd (KJC:IN), boosting the stock rating from Hold to Add. This shift comes alongside a slight decrease in the price target, which now stands at INR 1,405, down from the previous target of INR 1,433. This adjustment reflects the evolving market conditions and the company's performance metrics.

Analysis of Recent Financial Performance

The analysts at ICICI Securities highlighted that Kajaria Ceramics exhibited a modest performance in the second quarter of the financial year 2025. The consolidated revenue achieved a year-over-year growth of 5.1%, primarily driven by an 8.4% increase in tile volume sales. This level of growth resonates with the company's five-year compound annual growth rate of 7.8%, indicating a steady market presence.

Despite the positive revenue outlook, Kajaria Ceramics faced challenges with its EBITDA margin, which contracted significantly. Specifically, there was a reduction of 255 basis points year-over-year, and 153 basis points quarter-over-quarter, resulting in an EBITDA margin of 13.5%. This contraction was mainly a consequence of elevated operating expenses, notably stemming from lower utilization rates in their Keronite tile and new sanitaryware plants.

Margin and Profitability Trends

The decrease in gross margins, which fell by 184 basis points year-over-year and 90 basis points quarter-over-quarter, has also impacted profitability. This development contributed to a year-over-year decrease of 11.6% in EBITDA and a significant 21.9% drop in after-tax profit (APAT), underscoring the effects of rising operational costs and market pressures.

Management’s Outlook and Adjustments

Though Kajaria Ceramics witnessed moderate demand during the second quarter of FY25, the management team expressed optimism for improved volume growth during the latter half of the fiscal year. This positivity is largely tied to expectations of a thriving real estate market, which typically bolsters demand for tiles and related products.

In light of these insights, the company has revised its growth guidance for tile volumes, now targeting an increase of 9-10%. Although this marks a shift from earlier forecasts that anticipated double-digit growth, it reflects a realistic approach to market dynamics. Additionally, operating margins are expected to remain at the lower end of the previously anticipated range of 15-17% for FY25.

Revisions in EBITDA Estimates

As a consequence of these performance metrics and market fluctuations, ICICI Securities has lowered its EBITDA estimates for Kajaria Ceramics for the fiscal years 2025 to 2027. The revisions range between 4-8%, indicating a cautious outlook on the stock's future performance. The recent upgrade to an Add rating comes after a roughly 7% decline in Kajaria Ceramics' stock price over the preceding three months.

The new price target of INR 1,405 reflects a consistent 38 times price-to-earnings (P/E) ratio, further illustrating the analysts' comprehensive evaluation of the stock's value amidst changing conditions.

Frequently Asked Questions

What led to the upgrade of Kajaria Ceramics' stock by ICICI Securities?

The upgrade was influenced by modest revenue growth and expectations of improved performance, despite some declines in margins and profitability.

What is the new price target for Kajaria Ceramics?

The updated price target has been set at INR 1,405, down from INR 1,433.

What are the factors impacting Kajaria Ceramics' margins?

The margins are impacted by increased operating costs and decreased utilization rates at key production plants.

How has Kajaria Ceramics' stock performed recently?

The stock has seen a decline of approximately 7% over the past three months, prompting the rating adjustment.

What are Kajaria Ceramics' growth projections for FY25?

The company anticipates tile volume growth of 9-10%, along with operating margins expected to be at the lower end of the 15-17% range.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Sojo Industries Partners with Molex to Enhance Supply Chain Tracking

Updated Category News Views 270

Sojo Industries Collaborates with Molex for Innovation Sojo Industries is making waves in the smart supply chain market with its latest collaboration with Molex. This partnership aims to elevate the production capabilities of the Sojo Seal™, an advanced device designed for tracking consumer-packaged goods. By enhancing supply chain transparency, this collaboration...

Continue Reading
Exploring the Driving Forces Behind Biodegradable Plastics Growth

Updated Category News Views 37

Understanding the Biodegradable Plastics Market As the world leans towards sustainability, the biodegradable plastics market is witnessing an impressive transformation. It is projected to reach USD 28.7 billion, showcasing a remarkable compound annual growth rate of 15.2% from 2024 to 2032. This shift is mainly driven by our collective concern over plastic waste and its...

Continue Reading
Securing Justice: ALLR Investors Unite for Legal Action

Updated Category News Views 50

Opportunity for Investors to Lead Legal Action Investors holding securities of Allarity Therapeutics, Inc. (NASDAQ: ALLR) now have a significant opportunity to join a legal action concerning alleged securities fraud. The Schall Law Firm, which represents investors in shareholder rights litigation, has announced a class action lawsuit aimed at seeking justice and recovery...

Continue Reading
Unlocking Monthly Income from HPQ Stock: A Guide

Updated Category News Views 134

Understanding HP Inc. and Its Dividend Potential HP Inc. (NYSE: HPQ) is on the verge of announcing its fourth-quarter earnings, generating buzz among investors. With analysts predicting earnings of approximately 92 cents per share, down slightly from 93 cents last year, the interest in HPQ is palpable. The expected quarterly revenue stands at a robust $14.49 billion, an...

Continue Reading
Upcoming Extraordinary General Meeting for RomReal: Key Details

Updated Category News Views 64

Overview of RomReal's Extraordinary General Meeting RomReal is gearing up for an Extraordinary General Meeting, which is important for both shareholders and potential investors. This gathering will provide stakeholders with a chance to engage with the company’s management and discuss its strategic path ahead. Purpose of the Extraordinary General Meeting The main goal of...

Continue Reading